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ABSTRACT

ARTICLE HISTORY

Objective: To provide an Urdu translation of the six-item version of the Urogenital Distress
Inventory (UDI-6) and its validation in patients with urinary incontinence (UI), as the UDI-6 is
a recognised, useful disease-speciﬁc questionnaire for the evaluation of UI in women.
Patients and methods: We used a multi-step linguistic translation of the UDI-6, which
comprised backward and forward translations coordinated by clinical investigators, followed
by a pre-test in 10 patients. The ﬁnal version was completed by a larger sample of women
(n = 200), of which 100 had UI for the last 3 months and 100 had no UI. To appraise test–
retest reliability the patients with UI were re-tested after 2 weeks. To test the questionnaire’s
capacity to discriminate between women with or without UI, both cases (patients) and
controls were included and assessed. The reliability of the UDI-6 was evaluated by internal
consistency and was calculated using the Wilcoxon signed-rank test with P values, and test–
retest reliability assessed by Spearman’s coeﬃcient with P values.
Results: The reliability of the UDI-6 was assessed for internal consistency and test–retest
reliability was evaluated by Spearman’s coeﬃcient, which showed signiﬁcant P values.
Conclusion: The present Urdu version of the UDI-6 is a linguistically valid instrument that can
be reliably used in clinical practice and research.
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Introduction
According to the recommendations of the ICS/
International Urogynecological Association (IUGA)
joint report 2010, urinary incontinence (UI) is deﬁned
as ‘complaint of involuntary loss of urine’ [1].
The global prevalence of UI is ~49% for stress UI,
22% for urge UI, and 29% for mixed UI. UI is a very
common disorder aﬀecting females of all ages [2]. In
a study from Pakistan involving 180 female patients,
44% of females reported signiﬁcant UI, of which
17.2% and 16.1% complained of stress or mixed UI,
respectively, with 9.7% complaining of urge UI
only [3].
Various generic and disease-speciﬁc quality-of-life
(QoL) questionnaires, such as the six-item version of
the Urogenital Distress Inventory (UDI-6) and sevenitem version of the Incontinence Impact
Questionnaire (IIQ-7), are used to evaluate women
presenting with UI in the West. Generic questionnaires
use non-speciﬁc questions and are lengthy and complexity restricted. Therefore, it has been postulated
that the simultaneous use of generic and disease-

speciﬁc questionnaires will improve the sensitivity to
assess the impact of UI on the QoL of women [4]. This
sensitivity is increased if the questionnaire used is
translated into the population’s native language, as
conﬁrmed by various studies, and therefore validated
questionnaires, like the UDI-6 and IIQ-7, have been
translated into various languages including: Arabic,
Dutch and Turkish [5–8].
The national language of Pakistan is Urdu and many
Pakistanis’ are unfamiliar with even basic English language. There is no validated QoL instrument in the
Urdu language that can measure the impact of UI.
Therefore, the aim of our present study was to provide
an Urdu version of the UDI-6 questionnaire and validate its use in an Urdu-speaking population. As UI is
considered as a social taboo, a questionnaire validated
in the patient’s own language will help them report
their issues accurately and comfortably, and also provide a platform for future research.
The objective of the present study was to provide
an Urdu translation of the UDI-6 and its validation in
female patients with UI.
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Patients and methods
Study design
A cross-sectional study was conducted at the outpatient urology clinic over a 4-month period. Patients
(cases) were asked to complete the questionnaire at
baseline and 2 weeks later, so as to evaluate the test–
retest reliability. The controls were assessed only
once, as in patients with LUTS their symptoms
would be seen again for clinical reasons, whilst in
controls they would not. Therefore, the test–retest
reliability was performed on patients only. During
the study period, the questionnaires were completed
by the patients as well as the controls. However, the
translation process itself took 6–7 months prior to use.
The UDI includes 18 items; thus, a sample of 180
patients would be ideally required, so we included
200. The sample size of 200 was adequate to fulﬁll
the above criteria and objective measures of urinary
symptoms.
The inclusion criteria of the study were all female
patients aged ≥18 years reporting UI for the last
3 months. These were the cases. The controls were
all healthy subjects with no UI for the last 3 months.
The exclusion criteria included all those whose education status was below primary level, those with psychiatric diseases, and those with incomplete forms.
We also excluded those patients with language barriers. These were patients from distant places or from
other countries who did not understand Urdu or
English, and needed to have a translator present for
history taking and to follow various instructions during examination.
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original UDI-6 were compared, and the ﬁrst
version was revised.
(5) A pilot test was done, to assess whether the
UDI-6 was clear to the target population, in 10
patients (i.e., women with urological problems)
[10]. The number of patients who had problems
in correctly understanding the questions and
pre-coded answers were recorded and
discussed.
(6) The ﬁnal Urdu version of the UDI-6 was
devised.
The questionnaire was ﬁrst introduced at the
patient’s initial visit to the clinic and then at the ﬁrst
follow-up visit, which usually was 2 weeks later. Here
the questionnaire was re-introduced to the patients
and they completed it. The total number of participants was 200, of which 100 were cases and 100 were
controls.

Statistical analysis
The analysis was done using the Statistical Package
for the Social Sciences (SPSS®), version 20 (SPSS Inc.,
IBM Corp., Armonk, NY, USA). The sample size for this
study was 200 and the recommended subject-to-item
ratio of a given measurement scale should be 5:1 or
above. The reliability of the UDI-6 was assessed by
internal consistency and was calculated using the
Wilcoxon signed-rank test with P values, and test–
retest reliability was evaluated by Spearman’s coeﬃcient with P values.

Ethical considerations
Translation process
The validation process of any measure in a new language depends on a rigorous linguistic translation,
which permits conceptual and technical equivalence
between the original source and target language as
much as possible [9]. The following steps were performed for the linguistic validation:
(1) Translation of the UDI-6 from the original language (English) to Urdu was done by two independent Urdu-speaking translators with English
as their ﬁrst foreign language (Appendix S1).
(2) The ﬁrst consensus meeting included the two
translators and the research group, who compared the Urdu versions, and developed a ﬁrst
Urdu version of the UDI-6.
(3) A back-translation of this Urdu version was
done by a native English-speaking translator,
with Urdu as their ﬁrst foreign language.
(4) The second consensus meeting was held
between the English translator and investigators, during which the back-translation and the

Ethics approval for the study was granted by the local
institute.

Results
In the control group of 100 females the mean (SD)
age was 30 (8) years. In the cases group of 100
patients, the mean (SD) age was 46 (16) years.
Table 1 shows that the questionnaire was able to
discriminate primarily between the cases and controls,
by calculating medians with interquartile ranges
(IQRs).
Table 1. Comparison of median score (IQR) using Mann–
Whitney U-test between cases and control at baseline.
Median (IQR) score
UDI-6 symptoms
Frequency
Urgency
Stress UI
UI volume
Diﬃculty urinating
Pain

Cases
2 (1–3)
2 (1–3)
2 (1–3)
2 (1–3)
2 (1–3)
1 (1–3)

Controls
0 (0–1)
0 (0–1)
0 (0–1)
0 (0–1)
0 (0–1)
0 (0–1)

P*
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
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Table 2. Correlation between symptom severity at baselines
and 2 weeks.
Spearman’s ρ
0.845
0.901
0.887
0.855
0.993
1

UDI-6 symptom
Frequency
Urgency
Stress UI
UI volume
Diﬃculty urinating
Pain baseline

P
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

Table 3. Consistency between baseline and 2-week selfreported symptom severity amongst cases (n = 54).
Symptom severity
UDI-6 symptom
Frequency
Urgency
Stress UI
UI volume
Diﬃculty urinating
Pain baseline

Decreased
6
2
4
4
1
0

Increased
3
3
3
2
0
0

Unchanged
45
49
47
48
53
54

P
0.454
0.334
0.792
0.666
0.317
1.00

* Wilcoxon signed-ranks test was used to assess consistency between
baseline and 2-week self-reported symptom severity amongst cases.

The correlation between the baseline and 2-week
symptoms score was calculated in cases using
Spearman’s correlation coeﬃcient. These are the
values of each individual item at ﬁrst visit (baseline)
and at 2 weeks, as shown in scatter plots. This is done
to check the test–retest reliability, i.e., to see if each
item of the questionnaire, which the cases and controls have answered is the same after 2 weeks.
Table 2 shows the correlation between the baseline
and 2-week symptoms score in cases, which were
calculated using Spearman’s correlation coeﬃcient.
All of them show signiﬁcant P values, which means
that when looking at the test–retest reliability, all the
items were reliable and they can be used in a real
sense.
Internal consistency was calculated using Wilcoxon
signed-rank test (Table 3). The signiﬁcant P values
indicate that the correlation between the severities
of the symptoms was valid and consistent.

a Pearson’s coeﬃcient value of 0.8 [11]. In contrast,
the linguistic validation in Swedish language showed
an α coeﬃcient of 0.39 [12].
Generally, internal consistency is considered ‘good’
when the α coeﬃcient is >0.7. The internal consistency
was 0.76 for the original version by Wyman et al. [13] and
it was satisfactory in an Italian version by Artibani et al.
[14]. In our present study, the P values of all variables
were signiﬁcant, thus proving good internal consistency.
The present results show that the Urdu translation
of the UDI-6 is a reliable and valid instrument. All
forward and backward translations were consistent
with each other and the original English version. We
followed the standard translation method, consisting
of forward and backward translations, and
a consensus meeting between the clinical investigators and the translators. This process is a widely
accepted methodology for linguistic validation [10].

Conclusion
The present Urdu version of the UDI-6 is a valid instrument that can be reliably used in daily practice and
clinical research.
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Contributions
Discussion
The UDI-6 is a condition-speciﬁc QoL questionnaire,
which is simple to understand and provides a more
in-depth assessment of speciﬁc concerns related to UI
[6]. However, its validation in the Chinese language
proves that there may be cultural discrepancies and
language-speciﬁc issues, e.g., items may need to be
adjusted according to cultural diﬀerences in diﬀerent
populations [11]. We also plan to assess the need for
modiﬁcation according to our cultural needs in a later
study.
In the present study, there was a high correlation
between ratings, meaning that the questionnaire is
stable for short time-intervals. This is similar to various
studies where this questionnaire has been validated in
national languages, the validation in Chinese showed
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